Authors: Jiang H et al.
Canadian Journal of Anesthesia, April 24, 2026
This in vivo translational rodent study examined how phenylephrine (PE), a commonly used vasopressor in anesthesia, differentially affects microvascular perfusion in the brain versus skeletal muscle. Given that intraoperative hypotension is associated with poor outcomes, vasopressors like PE are frequently used to restore mean arterial pressure (MAP). However, concerns remain about whether increasing MAP with vasoconstriction may compromise regional tissue perfusion.
Using 48 rat models, the investigators measured microvascular blood flow via laser Doppler and tissue oxygenation (PO2) using phosphorescence quenching techniques. They specifically compared responses in brain tissue, skeletal muscle, and surgically created skeletal muscle free flaps.
The results demonstrated that phenylephrine effectively increased MAP and, importantly, increased cerebral microvascular blood flow and brain tissue oxygenation. This supports the concept that restoring systemic pressure with PE can improve cerebral perfusion.
In contrast, skeletal muscle showed a different response. Increasing doses of phenylephrine progressively reduced skeletal muscle microvascular blood flow. Despite this reduction in flow, tissue oxygenation (PO2) in skeletal muscle was preserved, suggesting either reduced metabolic demand or compensatory oxygen extraction.
The most striking findings were seen in skeletal muscle free flaps. These tissues already exhibited markedly reduced baseline perfusion and oxygenation, indicating a hypoxic state. Escalating doses of phenylephrine did not further worsen perfusion or oxygenation in these flaps. Elevated levels of hypoxia-inducible factor 1α (HIF-1α) confirmed significant underlying tissue hypoxia in the flap model.
Overall, the study highlights a key physiologic tradeoff: phenylephrine improves cerebral perfusion while reducing skeletal muscle blood flow. However, preserved tissue oxygenation in muscle suggests that decreased flow does not necessarily equate to tissue ischemia in all settings.
What You Should Know
Phenylephrine increases MAP and improves brain blood flow and oxygenation, supporting its role in protecting cerebral perfusion during hypotension.
Skeletal muscle blood flow decreases with phenylephrine, but oxygen delivery may still be adequate due to compensatory mechanisms.
Free flap tissue appears already compromised at baseline and is not further worsened by phenylephrine, though significant hypoxia exists.
These findings reinforce that MAP alone is not a perfect surrogate for tissue perfusion across all organ systems.
Tissue-specific monitoring (e.g., cerebral or tissue oximetry) may be more informative than relying solely on blood pressure targets.
Thank you to the Canadian Journal of Anesthesia for allowing us to summarize and share this important patient safety article.